Official Journal of the European Union. (Non-legislative acts) REGULATIONS

Transcription

1 EN L 251/1 II (Non-legislative acts) REGULATIONS COMMISSION REGULATION (EU) 2018/1480 of 4 October 2018 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures and correcting Commission Regulation (EU) 2017/776 (Text with EEA relevance) THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 ( 1 ), and in particular Article 37(5) and Article 53(1) thereof, Whereas: (1) Table 3.1 of Part 3 of Annex VI to Regulation (EC) No 1272/2008 contains the list of harmonised classification and labelling of hazardous substances based on the criteria set out in Parts 2 to 5 of Annex I to that Regulation. (2) Proposals to introduce harmonised classification and labelling of certain substances and to update or delete the harmonised classification and labelling of certain other substances have been submitted to the European Chemicals Agency pursuant to Article 37 of Regulation (EC) No 1272/2008. Based on the opinions on those proposals issued by the Committee for Risk Assessment of the Agency (RAC), as well as on the comments received from the parties concerned, it is appropriate to introduce, update or delete harmonised classification and labelling of certain substances. (3) Council Directive 67/548/EEC ( 2 ) and Directive 1999/45/EC of the European Parliament and of the Council ( 3 ) were repealed with effect from 1 June As a result, Part 3 of Annex VI to Regulation (EC) No 1272/2008 was amended by Commission Regulation (EU) 2016/1179 ( 4 ) to remove Table 3.2. That amendment took effect on 1 June Annex VI to Regulation (EC) No 1272/2008 was further amended by Commission Regulation (EU) 2017/776 ( 5 ) to delete references to Table 3.2, to convert references to Table 3.1 into references to Table 3 and to delete references to the repealed Directives. Under Article 2(2) of Regulation (EU) 2017/776, the majority of those amendments were to apply from 1 June 2017, while the remaining amendments were stated to apply from 1 December However, due to an oversight, Article 2(2) failed to list two further amendments that ( 1 ) OJ L 353, , p. 1. ( 2 ) Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (OJ 196, , p. 1). ( 3 ) Directive 1999/45/EC of the European Parliament and of the Council of 31 May 1999 concerning the approximation of laws, regulations and administrative provisions of the Member States relating to the classification, packaging and labelling of dangerous preparations (OJ L 200, , p. 1). ( 4 ) Commission Regulation (EU) 2016/1179 of 19 July 2016 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (OJ L 195, , p. 11). ( 5 ) Commission Regulation (EU) 2017/776 of 4 May 2017 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (OJ L 116, , p. 1).

2 L 251/2 EN should have applied from 1 June 2017, including in particular the amendment changing the name of the Table from Table 3.1 to Table 3. The second subparagraph of Article 2(2) of Regulation (EU) 2017/776 should therefore be corrected to include reference to those two amendments. This correction, although it has the effect of applying the two amendments retroactively, does not affect the rights and obligations of manufacturers, importers, downstream users or suppliers. (4) Regulation (EU) 2017/776 also amended Annex VI to Regulation (EC) No 1272/2008 to add harmonised Acute Toxicity Estimate (ATE) values in Table 3.1 as part of the information relating to the classification and labelling of certain substances for the purposes of the classification of mixtures. The ATE introduced for nicotine was expressed in mg/kg. In order to clarify how mixtures containing nicotine should be classified, the ATE for the oral and the dermal routes for nicotine should instead be expressed in mg/kg bw ( 1 ). The ATEs for three other substances, namely colecalciferol, 1,2-dihydroxybenzene and pinoxaden should also be expressed in the same way. In addition, in the title of the penultimate column of Table 3.1, a footnote should be added indicating what the abbreviation mg/kg bw stands for. (5) The Annex to Commission Regulation (EU) 2018/669 ( 2 ) provides for the translation of the names of the substances included in Table 3.1 of Annex VI to Regulation (EC) No 1272/2008. As a consequence, the title of the second column of that Table, which currently refers to international chemical identifications, should be amended to take account of the fact that the international chemical identifications will lose their international character once the Regulation providing for their translation in Annex VI becomes applicable. For the sake of consistency, this amendment should take effect when the translation of the names in Annex VI takes effect. The new title should reflect the terminology used in Article 18 of Regulation (EC) No 1272/2008. (6) Compliance with the new or updated harmonised classifications should not be required immediately as a certain period of time will be necessary to allow suppliers to adapt the labelling and packaging of substances and mixtures to the new or revised classifications and to sell existing stocks. That period of time will also be necessary to allow suppliers to adapt to and comply with other legislative obligations resulting from the new or updated harmonised classifications, such as those set out in Article 22(f) or Article 23 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council ( 3 ), those set out in Article 50 of Regulation (EU) No 528/2012 of the European Parliament and of the Council ( 4 ) or those set out in Article 44 of Regulation (EC) No 1107/2009 of the European Parliament and of the Council ( 5 ). (7) Regulation (EC) No 1272/2008 should therefore be amended accordingly. (8) In line with the transitional provisions of Regulation (EC) No 1272/2008 which allow for new provisions to be applied at an earlier stage on a voluntary basis, suppliers should be allowed to apply the new and updated harmonised classifications, and to adapt the labelling and packaging accordingly, on a voluntary basis before the date of application of those new or updated classifications. (9) The measures provided for in this Regulation are in accordance with the opinion of the Committee established by Article 133 of Regulation (EC) No 1907/2006, HAS ADOPTED THIS REGULATION: Article 1 Amendment to Regulation (EC) No 1272/2008 Annex VI to Regulation (EC) No 1272/2008 is amended as set out in the Annex to this Regulation. ( 1 ) Body weight. ( 2 ) Commission Regulation (EU) 2018/669 of 16 April 2018 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (OJ L 115, , p. 1). ( 3 ) Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (OJ L 396, , p. 1). ( 4 ) Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (OJ L 167, , p. 1). ( 5 ) Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (OJ L 309, , p. 1).

3 L 251/3 EN Article 2 Correction to Regulation (EU) 2017/776 In Regulation (EU) 2017/776, the second subparagraph of Article 2(2) is replaced by the following: In the Annex, point (1), point (2) and points (a), (b) and (c) of point (3) shall apply from 1 June Article 3 Entry into force and application This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. Point (1) and point (a) of point (2) of the Annex shall apply from 1 December Points (b), (c), (d) and (e) of point (2) of the Annex shall apply from 1 May By way of derogation from the third paragraph of this Article, substances and mixtures may, before 1 May 2020, be classified, labelled and packaged in accordance with Regulation (EC) No 1272/2008 as amended by this Regulation. This Regulation shall be binding in its entirety and directly applicable in all Member States. Done at Brussels, 4 October For the Commission The President Jean-Claude JUNCKER

4 Annex VI to Regulation (EC) No 1272/2008 is amended as follows: (1) in Part 1, the heading of point is replaced by the following: Chemical name ; (2) in Part 3, Table 3.1 is amended as follows: (a) the title of the second column is replaced by the following: Chemical name ; ANNEX (b) the title of the penultimate column is replaced by the following: (*) (*) ATEs for oral and dermal exposure routes are expressed in mg/kg bw, which stands for milligram per kilogram bodyweight. ; (c) the entry corresponding to index number is deleted; (d) the entries corresponding to index numbers , , , , , , , , , , , , , X, , , and are replaced by the following entries respectively: Index No Chemical name EC No CAS No isoproturon (ISO); 3-(4-isopropylphenyl)-1,1-dimethylurea Class and Category Carc. 2 STOT RE 2 H373 (blood) H373 (blood) M = 10 M = 10 L 251/4 EN phosmet (ISO); S-[(1,3-dioxo-1,3-dihydro-2Hisoindol-2-yl)methyl] O,O-dimethyl phosphorodithioate; O,O-dimethyl-S-phthalimidomethyl phosphorodithioate Repr. 2 STOT SE 1 H332 H370 H332 H

5 thifensulfuron-methyl (ISO); methyl 3-(4-methoxy-6- methyl-1,3,5-triazin-2-ylcarba moylsulfamoyl)thiophene-2- carboxylate sodium hypochlorite, solution % Cl active Class and Category Skin Corr. 1B potassium permanganate Ox. Sol. 2 Repr. 2 * colecalciferol; cholecalciferol; vitamin D Acute Tox. 2 Acute Tox. 2 Acute Tox. 2 STOT RE 1 H272 H361d H310 H300 H372 GHS03 H272 H361d H310 H300 H372 EUH031 M = 10 M = 1 EUH031: C 5 % inhalation: ATE = 0,05 mg/l (dusts or mists) dermal: ATE = 50 mg/kg bw oral: ATE = 35 mg/kg bw STOT RE 1; H372: C 3 % STOT RE 2; H373: 0,3 % C < 3 % B EN L 251/5

6 chlorocresol; 4-chloro-m-cresol; 4-chloro-3-methylphenol ,2-dihydroxybenzene; pyrocatechol Class and Category Skin Corr. 1C STOT SE 3 Skin Sens. 1B Aquatic Chronic Carc. 1Β Muta. 2 Skin Irrit. 2 Eye Irrit tert-butylphenol Repr. 2 Skin Irrit. 2 H412 H350 H341 H311 H315 H315 H350 H341 H311 H315 H315 oral: ATE = 300 mg/kg bw dermal: ATE = 600 mg/kg bw L 251/6 EN acetaldehyde; ethanal Flam. Liq. 1 Carc. 1B Muta. 2 STOT SE 3 Eye Irrit. 2 H224 H350 H341 GHS02 H224 H350 H benzyl-2-dimethylamino-4 - morpholinobutyrophenone Repr. 1B H360D H360D

7 Class and Category maleic anhydride STOT RE 1 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1A succinic anhydride Skin Corr. 1 Resp. Sens. 1 Skin Sens X isobutyl methacrylate Flam. Liq. 3 STOT SE 3 Skin Irrit. 2 Skin Sens. 1B quizalofop-p-tefuryl (ISO); (+/ ) tetrahydrofurfuryl (R)-2-[4-(6- chloroquinoxalin-2-yloxy)phenyloxy]propionate Carc. 2 Repr. 2 STOT RE 2 H372 (respiratory (inhalation) H334 H334 H226 H315 d H373 GHS02 H372 (respiratory (inhalation) H334 H334 H226 H315 d H373 EUH071 Skin Sens. 1A; : C 0,001 % EUH071 M = 1 D EN L 251/7

8 reaction mass of 5-chloro-2- methyl-2h-isothiazol-3-one and 2-methyl-2H-isothiazol-3- one (3:1) propiconazole (ISO); (2RS,4RS;2RS,4SR)-1-{[2-(2,4- dichlorophenyl)-4-propyl-1,3- dioxolan-2-yl]methyl}-1h- 1,2,4-triazole Class and Category Acute Tox. 2 Acute Tox. 2 Skin Corr. 1C Skin Sens. 1A Repr. 1B Skin Sens. 1 H310 H360D H310 H360D EUH071 Skin Corr. 1C; : C 0,6 % Skin Irrit. 2; H315: 0,06 % C < 0,6 % ; : C 0,6 % Eye Irrit. 2; : 0,06 % C < 0,6 % Skin Sens. 1A; : C 0,0015 % M = 1 B L 251/8 EN nicotine (ISO); 3-[(2S)-1-methylpyrrolidin-2- yl]pyridine Acute Tox. 2 Acute Tox. 2 Acute Tox. 2 Aquatic Chronic 2 H310 H300 H411 H310 H300 H411 inhalation: ATE = 0,19 mg/l (dusts or mists) dermal: ATE = 70 mg/kg bw oral: ATE = 5 mg/kg bw

9 (e) the following entries are inserted in the appropriate places, following the order of the entries set out in Table 3.1: Index No Chemical name EC No CAS No X isoeugenol; [1] (E)-2-methoxy-4-(prop-1-enyl) phenol; [2] (Z)-2-methoxy-4-(prop-1-enyl) phenol [3] ,3,5,6-tetrafluoro-4-(methoxymethyl)benzyl (1R,3R)-2,2-dimethyl-3-[(1Z)-prop-1-en-1-yl] cyclopropanecarboxylate; epsilon-metofluthrin isopropyl (2E,4E,7S)-11-meth oxy-3,7,11-trimethyldodeca- 2,4-dienoate; S-methoprene pinoxaden (ISO); 8-(2,6-diethyl-4-methylphenyl)- 7-oxo-1,2,4,5-tetrahydro-7Hpyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl 2,2-dimethylpropanoate [1] [2] [3] [1] [2] [3] Class and Category STOT SE 1 STOT RE Repr. 2 Eye Irrit. 2 STOT SE 3 Skin Sens. 1A Aquatic Chronic 3 Skin Sens. 1A H332 H370 H373 H361d H332 H412 Skin Sens. 1A; : C 0,01 % H332 H370 H373 M = 1 H361d H332 inhalation: ATE = 4,63 mg/l (dusts or mists) oral: ATE = 500 mg/kg bw EN L 251/9

10 tetramethrin (ISO); (1,3-dioxo-1,3,4,5,6,7-hexahydro-2H-isoindol-2-yl)methyl 2,2-dimethyl-3-(2-methylprop- 1-en-1-yl)cyclopropanecarboxylate (1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2- methylprop-1-enyl)cyclopropanecarboxylate Class and Category Carc. 2 STOT SE Carc. 2 STOT SE 2 H371 (inhalation) H371 (inhalation) H371 (inhalation) H371 (inhalation) L 251/10 EN mesosulfuron-methyl (ISO); methyl 2-[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-α-(methanesulfonamido)-p-toluate; spirodiclofen (ISO); 3-(2,4-dichlorophenyl)-2-oxo- 1-oxaspiro[4.5]dec-3-en-4-yl 2,2-dimethylbutyrate Carc. 1B Repr. 2 STOT RE 2 Skin Sens. 1B H350 H373 H350 H373 M =

11 X sodium methyl [(4-aminophenyl)sulphonyl]carbamate; sodium methyl (EZ)-sulfanilylcarbonimidate; asulam-sodium Class and Category Skin Sens salicylic acid Repr flutianil (ISO); (2Z)-{[2-fluoro-5-(trifluoromethyl)phenyl]thio}[3-(2-methoxyphenyl)-1,3-thiazolidin-2- ylidene]acetonitrile reaction mass of 1-[2-(2-aminobutoxy)ethoxy]but-2-ylamine and 1-({[2-(2-aminobutoxy)ethoxy]methyl}propoxy) but-2-ylamine H361d Repr. 2 Skin Corr. 1B methylisothiazol-3(2H)-one Acute Tox. 2 Skin Corr. 1B Skin Sens. 1A H311 H361d M = 1 H311 EUH071 EUH071 Skin Sens. 1A; : C 0,0015 % M = EN L 251/11

12 pyroxsulam (ISO); N-(5,7-dimethoxy[1,2,4]tria zolo[1,5-a]pyrimidin-2-yl)-2- methoxy-4-(trifluoromethyl) pyridine-3-sulfonamide Class and Category Skin Sens X 1-vinylimidazole Repr. 1B H360D amisulbrom (ISO); 3-(3-bromo-6-fluoro-2-methylindol-1-ylsulfonyl)-N,N-dimethyl-1H-1,2,4-triazole-1-sulfonamide Carc. 2 Eye Irrit. 2 H360D Repr. 1B; H360D: C 0,03 % M = 10 M = 10 L 251/12 EN